NeuImmune, Inc. — Form D
NeuImmune, Inc. of SYKESVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-15. The offering totals $20K, of which $20K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-15
- Form: D
- Accession: 0001860169-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20K
- Amount sold: $20K
- Minimum investment: $20K
- Investors: 1
- Date of first sale: 2021-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406464
Issuer
- Name: NeuImmune, Inc.
- CIK: 0001860169
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1500 FANNIE DORSEY RD, SYKESVILLE, MD, 21784
- Phone: 2403146507
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Kenneth C Carter | Director | SYKESVILLE, MD |
| Thomas R Fuerst | Director | SYKESVILLE, MD |
| Thomas R Fuerst | Executive Officer | SYKESVILLE, MD |
| Mark D Hankins | Executive Officer | SYKESVILLE, MD |
Other filings by this issuer (1)
More